View : 1054 Download: 0
Axillary Lymph Node-to-Primary Tumor Standard Uptake Value Ratio on Preoperative F-18-FDG PET/CT: A Prognostic Factor for Invasive Ductal Breast Cancer
- Title
- Axillary Lymph Node-to-Primary Tumor Standard Uptake Value Ratio on Preoperative F-18-FDG PET/CT: A Prognostic Factor for Invasive Ductal Breast Cancer
- Authors
- Kim, Young Hwan; Yoon, Hai-Jeon; Kim, Yemi; Kim, Bom Sahn
- Ewha Authors
- 김범산; 김예미; 윤혜전
- SCOPUS Author ID
- 김범산
; 김예미
; 윤혜전
- Issue Date
- 2015
- Journal Title
- JOURNAL OF BREAST CANCER
- ISSN
- 1738-6756
2092-9900
- Citation
- JOURNAL OF BREAST CANCER vol. 18, no. 2, pp. 173 - 180
- Keywords
- Breast neoplasms; Fluorodeoxyglucose F18; Lymph nodes; Prognosis
- Publisher
- KOREAN BREAST CANCER SOC
- Indexed
- SCIE; SCOPUS; KCI

- Document Type
- Article
- Abstract
- Purpose: This study assessed the axillary lymph node (ALN)-to-primary tumor maximum standard uptake value (SUVmax.) ratio (ALN/T SUV ratio) in invasive ductal breast cancer (IDC) on preoperative F-18-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) to determine the effectiveness in predicting recurrence-free survival (RFS). Methods: One hundred nineteen IDC patients (mean age, 50.5 +/- 10.5 years) with pathologically proven ALN involvement without distant metastasis and preoperative FDG PET/CT were enrolled in the study. SUVmax values of the ALN and primary tumor were obtained on FDG PET/CT, and ALN/T SUV ratio was calculated. Several factors were evaluated for their effectiveness in predicting RFS. These included several parameters on FOG PET/CT as well as several clinicopathological parameters: pathologic tumor/node stage; nuclear and histological grade; hormonal state; status with respect to human epidermal growth factor receptor 2, mindbomb E3 ubiquitin protein ligase 1 (MIB-1), and p53; primary tumor size; and ALN size. Results: Among 119 patients with breast cancer, 17 patients (14.3%) experienced relapse during follow-up (mean follow-up, 28.4 months). The ALN/T SUV ratio of the group with disease recurrence was higher than that of the group without recurrence (0.97 +/- 1.60 and 0.45 +/- 0.40, respectively, p=0.005). Univariate analysis showed that the primary tumor SUVmax, ALN SUVmax, ALN/T SUV ratio, ALN status, nuclear and histological grade, estrogen receptor (ER) status, and MIB-1 status were predictors for RFS. Among these variables, ALN/T SUV ratio with hazard ratio of 4.20 (95% confidence interval [CI], 1.74-10.13) and ER status with hazard ratio of 4.33 (95% CI, 1.06-17.71) were predictors for RFS according to multivariate analysis (p=0.002 and p=0.042, respectively). Conclusion: Our study demonstrated that ALN/T SUV ratio together with ER status was an independent factor for predicting relapse in IDC with metastatic ALN. ALN/T SUV ratio on preoperative FDG PET/CT may be a useful marker for selecting IDC patients that need adjunct treatment to prevent recurrence.
- DOI
- 10.4048/jbc.2015.18.2.173
- Appears in Collections:
- 의과대학 > 의학과 > Journal papers
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML